Skip to main content
KNSA logo

KNSA · Kiniksa Pharmaceuticals International, plc · Held by Funds

Track KNSA — free
$93.90 +0.36 (+0.38%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$7.38B
Shares
78.57M
Volume · Nov 20 545.23K Avg daily vol (3M) 658.72K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of KNSA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 3.92% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.10% 78,029
Index ETFs 3.82% 3,001,852
Active ETFs 0.35% 277,744
Active funds 1.66% 1,307,663
Unclassified 0.06% 44,207
All registered funds 5.99% 4,709,495
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding KNSA

75 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 75 positions
Key facts CIK 1730430 CUSIP G52694109 13F (30d) 280 filings 272 filers Visit website Investor relations